Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × INDUSTRY × zilucoplan × Clear all

Phase

Status

Completed 4 Recruiting 1 Enrolling by invitation 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

pembrolizumab 210 Carboplatin 149 Injections 110 Paclitaxel 104 Cisplatin 104 Bevacizumab 100 Gemcitabine 98 Pemetrexed 70 Docetaxel 70 Cyclophosphamide 52 Capecitabine 49 Fluorouracil 47 Oxaliplatin 45 Fulvestrant 45 Cetuximab 44 Nivolumab 43 130-nm albumin-bound paclitaxel 42 Dexamethasone 39 atezolizumab 37 Rituximab 37 venetoclax 35 fludarabine 35 Leucovorin 35 toripalimab 32 Lenalidomide 32 enzalutamide 30 durvalumab 30 Drug Therapy 30 Prednisone 27 Azacitidine 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06055959 2026-02-27

ziMyG

UCB Pharma

Phase 2/3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡